United Therapeutics (UTHR) Tops Q3 EPS by 82c, Beats on Revenues
Tweet
Share
E-mailGet Alerts UTHR Hot Sheet
Price: $554.34 -1.66%
Revenue Growth %: +1.5%
Financial Fact:
Total other (expense) income, net: 500K
Today's EPS Names:
CRMT, PKE, HELE, More
Revenue Growth %: +1.5%
Financial Fact:
Total other (expense) income, net: 500K
Today's EPS Names:
CRMT, PKE, HELE, More
Join SI Premium – FREE
United Therapeutics (NASDAQ: UTHR) reported Q3 EPS of $4.69, $0.82 better than the analyst estimate of $3.87. Revenue for the quarter came in at $446 million versus the consensus estimate of $426.43 million.
For earnings history and earnings-related data on United Therapeutics (UTHR) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- AZZ, Inc. (AZZ) Tops Q1 EPS by 16c, Offers Guidance
- PriceSmart (PSMT) Misses Q3 EPS by 4c, Beats on Revenue
- ExxonMobil (XOM) PT Lowered to $170 at Mizuho
Create E-mail Alert Related Categories
Earnings, GuidanceRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
